Denosumab for Prevention of Fractures in Postmenopausal Women with OsteoporosisSteven R. Cummings, Claus Christiansen, Štěpán Kutílek et al.|New England Journal of Medicine|2009Cited by 3.4k
Efficacy of Bazedoxifene in Reducing New Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis: Results From a 3-Year, Randomized, Placebo-, and Active-Controlled Clinical TrialStuart L. Silverman, Arkadi Chines, Claus Christiansen et al.|Journal of Bone and Mineral Research|2008Cited by 505
Effects of teriparatide versus alendronate for treating glucocorticoid‐induced osteoporosis: Thirty‐six–month results of a randomized, double‐blind, controlled trialKenneth G. Saag, Margaret R. Warner, José Zanchetta et al.|Arthritis & Rheumatism|2009Cited by 494
The effect of teriparatide compared with risedronate on reduction of back pain in postmenopausal women with osteoporotic vertebral fracturesPeyman Hadji, John L. Stock, José Zanchetta et al.|Osteoporosis International|2011Cited by 135
Reduced risk of back pain following teriparatide treatment: a meta-analysisMichael C. Nevitt, John H. Krege, Robin K. Dore et al.|Osteoporosis International|2005Cited by 132